+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
AB Science - logo

AB Science is a pharmaceutical company specializing in the discovery, development, and commercialization of novel targeted therapies named protein kinase inhibitors. Their therapies treat diseases such as cancers, inflammatory diseases, and central nervous system diseases in both human and veterinary medicine. It serves hospitals and specialist physicians. The company was founded in 2001 and is headquartered in Paris, France.

Chronic Obstructive Pulmonary Disease (COPD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Chronic Obstructive Pulmonary Disease (COPD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 541 Pages
  • Global
From
Head and Neck Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Head and Neck Cancer Therapeutics - Global Strategic Business Report

  • Report
  • June 2025
  • 93 Pages
  • Global
From
Neurodegenerative Diseases Therapeutics Market 2025-2029 - Product Thumbnail Image

Neurodegenerative Diseases Therapeutics Market 2025-2029

  • Report
  • April 2025
  • 251 Pages
  • Global
From
Amyotrophic Lateral Sclerosis Treatment Market by Treatment, Type, Treatment Stage, Route of Administration, Distribution Channel - Global Forecast to 2030 - Product Thumbnail Image

Amyotrophic Lateral Sclerosis Treatment Market by Treatment, Type, Treatment Stage, Route of Administration, Distribution Channel - Global Forecast to 2030

  • Report
  • May 2025
  • 188 Pages
  • Global
From
Amyotrophic Lateral Sclerosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Thumbnail Image

Amyotrophic Lateral Sclerosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • April 2023
  • 397 Pages
  • Global
From
Multiple Sclerosis (MS) Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2030 - Product Thumbnail Image

Multiple Sclerosis (MS) Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2030

  • Drug Pipelines
  • April 2023
  • 117 Pages
  • Global
From
Amyotrophic Lateral Sclerosis Treatment Market 2024-2028 - Product Thumbnail Image

Amyotrophic Lateral Sclerosis Treatment Market 2024-2028

  • Report
  • October 2023
  • 157 Pages
  • Global
From
Systemic Mastocytosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Systemic Mastocytosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 53 Pages
  • Global
From
Canine Atopic Dermatitis Market Report by Drug Class Type, Route of Administration, Distribution Channel, and Region 2024-2032 - Product Thumbnail Image

Canine Atopic Dermatitis Market Report by Drug Class Type, Route of Administration, Distribution Channel, and Region 2024-2032

  • Report
  • September 2024
  • 140 Pages
  • Global
From
Gastrointestinal Stromal Tumors Therapeutics Market 2025-2029 - Product Thumbnail Image

Gastrointestinal Stromal Tumors Therapeutics Market 2025-2029

  • Report
  • June 2025
  • 214 Pages
  • Global
From
Amyotrophic Lateral Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Amyotrophic Lateral Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 672 Pages
  • Global
From
Gastrointestinal Stromal Tumor (GIST) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Gastrointestinal Stromal Tumor (GIST) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 155 Pages
  • Global
From
Amyotrophic Lateral Sclerosis Treatment Market Report by ALS Type, Drug Type, Diagnosis Type, Treatment, Distribution Channel, and Region 2025-2033 - Product Thumbnail Image

Amyotrophic Lateral Sclerosis Treatment Market Report by ALS Type, Drug Type, Diagnosis Type, Treatment, Distribution Channel, and Region 2025-2033

  • Report
  • April 2025
  • 140 Pages
  • Global
From
Neurodegenerative Disorder Therapeutics Market Report 2025 - Product Thumbnail Image

Neurodegenerative Disorder Therapeutics Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Peritoneal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Peritoneal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 925 Pages
  • Global
From
Rheumatoid Arthritis - Pipeline Review, H2 2020 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 1191 Pages
  • Global
From
Gastric Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

Gastric Cancer- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 550 Pages
  • Global
From
Lou Gehrig's Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Lou Gehrig's Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Multiple Sclerosis - Pipeline Insight, 2025 - Product Thumbnail Image

Multiple Sclerosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Insight, 2025 - Product Thumbnail Image

Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator